Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Ocul Immunol Inflamm. 2021 May 19;29(4):677-680. doi: 10.1080/09273948.2021.1894457. Epub 2021 Apr 8.
: Herein, we report a case of bilateral neuroretinitis and panuveitis in a patient recovered from coronavirus disease 2019 (COVID-19).: A 37-year-old male patient with a history of recovered COVID-19, which was confirmed with nasopharyngeal reverse transcriptase polymerase chain reaction (RT-PCR) for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), about one-month ago was referred with one-week history of bilateral severe vision loss. Visual acuity was counting fingers, and bilateral retinitis and panuveitis were revealed in ocular examination. The result of the vitreous sample using RT-PCR was positive for SARS-CoV-2 and negative for viruses and . The patient was successfully treated with corticosteroid.: We report a case of bilateral neuroretinitis and panuveitisin a recovered COVID-19 patient and positive RT-PCR of the vitreous sample. It is suggested to apply intraocular sampling and evaluation for COVID-19 in patients with the new-onset of uveitis and/or retinitis during the pandemic.
: 本文报告了一例 COVID-19 患者恢复后出现双侧神经视网膜炎和全葡萄膜炎。: 一名 37 岁男性患者，有 COVID-19 病史，经鼻咽逆转录酶聚合酶链反应（RT-PCR）确诊为严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2），大约一个月前因双侧视力严重下降而被转诊。视力为指数，眼部检查显示双侧视网膜炎和全葡萄膜炎。玻璃体样本的 RT-PCR 结果为 SARS-CoV-2 阳性，病毒和 均为阴性。该患者经皮质类固醇治疗成功。: 我们报告了一例 COVID-19 恢复期患者出现双侧神经视网膜炎和全葡萄膜炎，且玻璃体样本的 RT-PCR 为阳性。建议在大流行期间，对新发葡萄膜炎和/或视网膜炎患者进行眼内取样和 COVID-19 评估。
